{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T20:45:07Z","timestamp":1788209107220,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cardiovascular Medicine"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.tcm.2021.03.005","type":"journal-article","created":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T19:19:24Z","timestamp":1616786364000},"page":"228-233","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Primary aldosteronism"],"prefix":"10.1016","volume":"32","author":[{"given":"John","family":"Funder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tcm.2021.03.005_bib0001","doi-asserted-by":"crossref","unstructured":"Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, et\u00a0al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endo Metab 93(9): 3226-3281.","DOI":"10.1210\/jc.2008-0104"},{"issue":"5","key":"10.1016\/j.tcm.2021.03.005_bib0002","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis and treatment: an endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endo Metab"},{"key":"10.1016\/j.tcm.2021.03.005_bib0003","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1055\/a-1120-8623","article-title":"Primary aldosteronism: where are we now? Where to from here?","volume":"52","author":"Funder","year":"2020","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.tcm.2021.03.005_bib0004","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/BF01476798","article-title":"Evidence for a subgroup of essential hypertensives with non-suppressible excretion of aldosterone during sodium loading","volume":"58","author":"Helber","year":"1980","journal-title":"Klin Wochenschr"},{"key":"10.1016\/j.tcm.2021.03.005_bib0005","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1126\/science.1198785","article-title":"K+ channel mutations in adrenal aldosterone producing adenomas and hereditary hypertension","volume":"331","author":"Choi","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.tcm.2021.03.005_bib0006","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1161\/HYPERTENSIONAHA.111.186478","article-title":"Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism","volume":"59","author":"Boulkroun","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.tcm.2021.03.005_bib0007","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1161\/HYPERTENSIONAHA.111.186239","article-title":"Somatic mutations affecting the selectivity filter of KCNJ5 are frequent in 2 large unselected collections of adrenal aldosteronomas","volume":"59","author":"Azizan","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.tcm.2021.03.005_bib0008","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2011-2965","article-title":"Microarray, qPCR, and KCNJ5 sequencing of aldosterone-producing adenomas reveal differences in genotype and phenotype between zona glomerulosa- and zona fasciculata-like tumors","volume":"97","author":"Azizan","year":"2012","journal-title":"J Clin Endo Metab"},{"key":"10.1016\/j.tcm.2021.03.005_bib0009","doi-asserted-by":"crossref","first-page":"E1567","DOI":"10.1210\/jc.2011-3132","article-title":"Effect of KCNJ5 mutations on gene expression in aldosterone-producing adenomas and adrenocortical cells","volume":"97","author":"Monticone","year":"2012","journal-title":"J Clin Endo Metab"},{"key":"10.1016\/j.tcm.2021.03.005_bib0010","doi-asserted-by":"crossref","first-page":"e41926","DOI":"10.1371\/journal.pone.0041926","article-title":"Comprehensive re-sequencing of adrenal aldosterone producing lesions reveals three somatic mutations near the KCNJ5 channel selectivity filter","volume":"7","author":"Akerstrom","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.tcm.2021.03.005_bib0011","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1210\/jc.2011-2885","article-title":"Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas","volume":"97","author":"Taguchi","year":"2012","journal-title":"J Clin Endo Metab"},{"key":"10.1016\/j.tcm.2021.03.005_bib0012","doi-asserted-by":"crossref","DOI":"10.5551\/jat.24455","article-title":"Comparison of cardiovascular complications in patients with and without KCNJ5 gene mutations harboring aldosterone producing adenomas","volume":"22","author":"Kitamoto","year":"2015","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.tcm.2021.03.005_bib0013","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1161\/HYPERTENSIONAHA.114.03346","article-title":"Clinical characteristics of somatic mutations in Chinese patients with aldosterone producing adenomas","volume":"65","author":"Zheng","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.tcm.2021.03.005_bib0014","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41588-018-0048-5","article-title":"CLCN2 chloride channel mutations in familial hyperaldosteronism Type 11","volume":"50","author":"Scholl","year":"2018","journal-title":"Nat Genet"},{"key":"10.1016\/j.tcm.2021.03.005_bib0015","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41588-018-0053-8","article-title":"A gain-of-function mutation in the CNCL2 chloride channel causes primary aldosteronism","volume":"50","author":"Fernandes-Rosa","year":"2018","journal-title":"Nat Genet"},{"key":"10.1016\/j.tcm.2021.03.005_bib0016","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1210\/jc.2018-01004","article-title":"Targeted molecular characterization of aldosterone producing adenomas in white Americans","volume":"103","author":"Nanba","year":"2018","journal-title":"J Clin Endo Metab"},{"key":"10.1016\/j.tcm.2021.03.005_bib0017","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1161\/HYPERTENSIONAHA.118.12070","article-title":"Genetic characteristics of aldosterone producing adenomas in blacks","volume":"73","author":"Nanba","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.tcm.2021.03.005_bib0018","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/HYPERTENSIONAHA.118.11086","article-title":"Cellular and genetic causes of idiopathic primary aldosteronism","volume":"72","author":"Omata","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.tcm.2021.03.005_bib0019","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/j.1365-2362.2011.02531.x","article-title":"High prevalence of autonomous aldosterone secretion among patients with essential hypertension","volume":"41","author":"Gouli","year":"2011","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.tcm.2021.03.005_bib0020","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1210\/clinem\/dgaa703","article-title":"Aldosterone is aberrantly regulated by various stimuli in a high proportion of patients with primary aldosteronism","volume":"106","author":"St-Jean","year":"2021","journal-title":"J Clin Endo Metab"},{"key":"10.1016\/j.tcm.2021.03.005_bib0021","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1161\/HYPERTENSIONAHA.116.08952","article-title":"Continuum of renin-independent aldosteronism in normotension","volume":"69","author":"Baudrand","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.tcm.2021.03.005_bib0022","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1210\/jc.2015-1268","article-title":"Stress-induced aldosterone hyper-secretion in a substantial subset of patients with essential hypertension","volume":"100","author":"Markou","year":"2015","journal-title":"J Endocrinol Metab"},{"key":"10.1016\/j.tcm.2021.03.005_bib0023","doi-asserted-by":"crossref","unstructured":"Brown J, Siddiqui M, Calhoun DA, Carey RB, Hopkins PN, Williams GH, et\u00a0al. The unrecognized prevalence of primary aldosteronism. Ann Intern Med 202: 173: 10-20.","DOI":"10.7326\/M20-0065"},{"issue":"1","key":"10.1016\/j.tcm.2021.03.005_bib0024","doi-asserted-by":"crossref","first-page":"65","DOI":"10.7326\/M20-1758","article-title":"Primary aldosteronism: at the tipping point","volume":"173","author":"Funder","year":"2020","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.tcm.2021.03.005_bib0025","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/ajh\/hpaa151","article-title":"Variability of aldosterone measurements during adrenal venous sampling for primary aldosteronism","volume":"18","author":"Yozamp","year":"2021","journal-title":"Am J Hypertens"},{"issue":"3","key":"10.1016\/j.tcm.2021.03.005_bib0026","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1161\/HYPERTENSIONAHA.120.16429","article-title":"Intra-individual variability of aldosterone concentrations in primary aldosteronism: implications for case detection","volume":"77","author":"Yozamp","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.tcm.2021.03.005_bib0027","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","article-title":"International society of hypertension global hypertension practice guidelines","volume":"75","author":"Unger","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.tcm.2021.03.005_bib0028","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S2213-8587(17)30367-4","article-title":"Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study","volume":"6","author":"Hundemer","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.tcm.2021.03.005_bib0029","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.jacc.2020.02.052","article-title":"Primary aldosteronism in patients in China with recently detected hypertension","volume":"75","author":"Xu","year":"2020","journal-title":"JACC"},{"key":"10.1016\/j.tcm.2021.03.005_bib0030","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","article-title":"Primary aldosteronism surgery outcome (PASO investigators: outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and remission rates in an international cohort","volume":"5","author":"Williams","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.tcm.2021.03.005_bib0031","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"}],"container-title":["Trends in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173821000438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173821000438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T05:01:25Z","timestamp":1760936485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1050173821000438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S1050173821000438"],"URL":"https:\/\/doi.org\/10.1016\/j.tcm.2021.03.005","relation":{},"ISSN":["1050-1738"],"issn-type":[{"value":"1050-1738","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary aldosteronism","name":"articletitle","label":"Article Title"},{"value":"Trends in Cardiovascular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tcm.2021.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}